{{Rsnum
|rsid=17623382
|Gene=BRAF
|Chromosome=7
|position=140892427
|Orientation=plus
|GMAF=0.06107
|Gene_s=BRAF
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 1.8 | 23.0 | 75.2
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 1.8 | 10.5 | 87.7
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 1.0 | 99.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 13.8 | 86.2
| MKK | 0.0 | 5.1 | 94.9
| TSI | 1.0 | 15.7 | 83.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22437554
|Trait=None
|Title=Genome-wide association study identifies three common variants associated with serologic response to vitamin E supplementation in men.
|RiskAllele=G
|Pval=0.000004
|OR=0.7800
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=19240718
|Title=Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}